Wegovy® (semaglutide)
If you are looking to obtain Wegovy® through online means to assist with your weight loss efforts, then Dr. Kalou is available to provide assistance. Consult with Dr. Kalou to determine if Wegovy® is the appropriate option for reaching a healthy body mass index (BMI).
Self-administered injectable prescription
Reduces risk of heart attacks and stroke
15% average weight loss over a year
What is Wegovy®?
Wegovy® is a groundbreaking medical development that can contribute to a healthier weight, leading to increased energy, improved self-esteem, and a reduced risk of chronic health conditions like cardiovascular disease, high cholesterol, and high blood pressure.
This self-administered injectable medication is designed to be placed under the skin and is available by prescription for patients with a body mass index (BMI) of 30 kg/m2 or higher, or a BMI of 27 kg/m2 or higher with at least one weight-related ailment such as type 2 diabetes, hypertension, or sleep apnea.
Selecting the appropriate weight loss treatment is a personal decision that should be made in consultation with your doctor. Our convenient telemedicine appointments provide patients with expert medical support to assist them in achieving their health objectives.
In today's fast-paced world, we bring top-notch medical care right to your doorstep. Wegovy® works in conjunction with a healthy diet and exercise routine to effectively manage weight in the long term. It is available in various doses, beginning at 0.25 mg and reaching a maximum of 2.4 mg, and comes in a convenient pen-injector form.
Wegovy® for Weight Loss
FDA Approved: The FDA has approved the use of Wegovy® as a weight loss medication for patients who are obese or overweight and have another weight-related condition, such as type 2 diabetes or high blood pressure.
Benefits: Obesity is a serious health issue that can lead to various health problems, like heart disease, diabetes, sleep apnea, and certain types of cancer. Losing just five to ten percent of body weight can significantly improve a person's health, including reducing the risk of heart disease, increasing energy levels, and improving blood pressure, blood sugar, and cholesterol levels.
History: On June 4, 2021, the FDA officially approved the use of Wegovy® for adults suffering from obesity or being overweight. It is the first chronic weight management medication to receive approval since 2014. When combined with a reduced-calorie meal plan and increased physical activity, Wegovy® has shown to be highly effective in helping individuals lose weight.
At our practice, we strive to provide personalized solutions for our patients and recognize Wegovy® as a top choice for weight management. However, we also want to mention other alternatives that may be more suitable for some patients. Dr. Kalou may suggest other GLP-1 options based on individual preferences and availability.
Other Options: Examples of these options include compounded semaglutide, which contains the same active ingredient as Wegovy® and has also proven to be effective in weight management. Another option is Zepbound®, which is a dual-action GLP-1 and GIP receptor agonist that not only helps regulate blood sugar levels but also shows potential in promoting weight loss.
Wegovy® side effects
Common side effects experienced by patients on Wegovy® include nausea, diarrhea, vomiting, and constipation.
Nausea
Diarrhea
Vomiting
Constipation
Abdominal pain
Headache
Fatigue
More serious side effects include thyroid tumors, including cancer, pancreatitis, gallbladder and kidney problems, and changes in mood.
Questions Our Patients Ask About Wegovy®
-
If you are having difficulties with losing weight and have a body mass index (BMI) of 30 kg/m2 or higher, or a BMI of 27 kg/m2 or higher accompanied by at least one weight-related illness, consider consulting with Dr. Kalou about trying Wegovy®.
The assessment for Wegovy® can be completed through an online platform, which will involve discussing your medical background and current medications to determine your eligibility for a prescription of Wegovy®.
-
Wegovy® has been proven to be effective in promoting weight loss. Studies have shown that individuals who have taken it for approximately one year were able to lose an average of 15% of their body weight. In many instances, we’ve seen patients lose much more weight.
-
During a 68-week clinical trial, individuals who received treatment with Wegovy® experienced an average weight loss of 15%. This equated to a mean reduction of 33 pounds. Conversely, participants who were not treated with Wegovy® only lost an average of six pounds. For optimal results, this weight loss medication should be used in conjunction with a low-calorie diet and regular exercise.
-
FDA approval of Wegovy® is for chronic or long-term weight management. Following achievement of your target weight, your Dr. Kalou will devise a personalized plan to ensure continued success.
-
Wegovy® works by boosting the function of GLP-1, a hormone that naturally occurs in our bodies. This hormone is typically released after meals and helps regulate blood sugar levels, curb cravings, slow digestion, and promote feelings of fullness. By increasing levels of GLP-1, Wegovy® allows you to experience these benefits with smaller food portions. This can aid in weight loss by supporting adherence to a reduced-calorie diet and leading to long-term weight loss.
Our clinic is dedicated to providing accurate information. The information provided is based upon studies published in The New England Journal of Medicine, SAGE Journals, and Novo Nordisk.